Onconetix (ONCO)
NASDAQ:ONCO
Total Valuation
Onconetix has a market cap or net worth of $1.09M. The enterprise value is $36.13K.
Market Cap$1.09M
Enterprise Value$36.13K
Share Statistics
Onconetix has 716,849 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding716,849
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Onconetix’s return on equity (ROE) is -0.89 and return on invested capital (ROIC) is -40.12%.
Return on Equity (ROE)-0.89
Return on Assets (ROA)-0.56
Return on Invested Capital (ROIC)-40.12%
Return on Capital Employed (ROCE)-0.40
Revenue Per Employee67.95K
Profits Per Employee-1.17M
Employee Count12
Asset Turnover0.03
Inventory Turnover1.22
Valuation Ratios
The current PE Ratio of Onconetix is ―. Onconetix’s PEG ratio is 0.02.
PE Ratio―
PS Ratio31.40
PB Ratio1.62
Price to Fair Value1.62
Price to FCF-2.64
Price to Operating Cash Flow-0.52
PEG Ratio0.02
Income Statement
In the last 12 months, Onconetix had revenue of 815.37K and earned -14.03M in profits. Earnings per share was -4.73.
Revenue815.37K
Gross Profit632.91K
Operating Income-6.34M
Pretax Income-14.03M
Net Income-14.03M
EBITDA-6.33M
Earnings Per Share (EPS)-4.73
Cash Flow
In the last 12 months, operating cash flow was -9.68M and capital expenditures 3.00, giving a free cash flow of -9.68M billion.
Operating Cash Flow-9.68M
Free Cash Flow-9.68M
Free Cash Flow per Share-13.50
Dividends & Yields
Onconetix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.42
52-Week Price Change-95.03%
50-Day Moving Average4.27
200-Day Moving Average12.37
Relative Strength Index (RSI)33.94
Average Volume (3m)207.81K
Important Dates
Onconetix upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Onconetix as a current ratio of 0.66, with Debt / Equity ratio of 0.31%
Current Ratio0.66
Quick Ratio0.65
Debt to Market Cap<0.01
Net Debt to EBITDA0.82
Interest Coverage Ratio-8.45
Taxes
In the past 12 months, Onconetix has paid 525.00 in taxes.
Income Tax525.00
Effective Tax Rate>-0.01
Enterprise Valuation
Onconetix EV to EBITDA ratio is -3.23, with an EV/FCF ratio of -2.11.
EV to Sales25.05
EV to EBITDA-3.23
EV to Free Cash Flow-2.11
EV to Operating Cash Flow-2.11
Balance Sheet
Onconetix has $5.22M in cash and marketable securities with $48.77K in debt, giving a net cash position of $5.17M billion.
Cash & Marketable Securities$5.22M
Total Debt$48.77K
Net Cash$5.17M
Net Cash Per Share$7.21
Tangible Book Value Per Share-$0.85
Margins
Gross margin is 77.62%, with operating margin of -778.16%, and net profit margin of -1720.98%.
Gross Margin77.62%
Operating Margin-778.16%
Pretax Margin-1720.91%
Net Profit Margin-1720.98%
EBITDA Margin-776.30%
EBIT Margin-778.16%
Analyst Forecast
The average price target for Onconetix is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-34.58%
EPS Growth Forecast96.41%